DiaMedica Therapeutics Inc. - notizie pubblicate 174 - letture 1.759


DiaMedica Therapeutics Inc.

DIAMEDICA THERAPEUTICS INC.

DiaMedica Therapeutics to Present at Lake Street’s 6th Annual Best Ideas Growth Conference

Minneapolis--(business wire)-- diamedica therapeutics inc. (nasdaq: dmac), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disord ...

06.09.2022
DiaMedica Therapeutics Inc.

DIAMEDICA THERAPEUTICS INC.

Material Event - Form 8-K

Dmtp20220211_8k.htm united states securities and exchange commission washington, d.c. 20549 __________________ form 8-k current report pursuant to section 13 or 15(d) of the securi ...

11.02.2022
DiaMedica Therapeutics Inc.

DIAMEDICA THERAPEUTICS INC.

Statement of Changes in Beneficial Ownership (Form 4)

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

02.02.2022
DiaMedica Therapeutics Inc.

DIAMEDICA THERAPEUTICS INC.

Initial Statement of Beneficial Ownership (Form 3)

Ownership submission form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section ...

02.02.2022
DiaMedica Therapeutics Inc.

DIAMEDICA THERAPEUTICS INC.

Statement of Changes in Beneficial Ownership (Form 4)

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

05.01.2022
DiaMedica Therapeutics Inc.

DIAMEDICA THERAPEUTICS INC.

Initial Statement of Beneficial Ownership (Form 3)

Ownership submission form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section ...

05.01.2022
DiaMedica Therapeutics Inc.

DIAMEDICA THERAPEUTICS INC.

Statement of Changes in Beneficial Ownership (Form 4)

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

03.01.2022
DiaMedica Therapeutics Inc.

DIAMEDICA THERAPEUTICS INC.

Statement of Changes in Beneficial Ownership (Form 4)

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

03.01.2022
DiaMedica Therapeutics Inc.

DIAMEDICA THERAPEUTICS INC.

Statement of Changes in Beneficial Ownership (Form 4)

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

03.01.2022
DiaMedica Therapeutics Inc.

DIAMEDICA THERAPEUTICS INC.

Statement of Changes in Beneficial Ownership (Form 4)

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

03.01.2022
DiaMedica Therapeutics Inc.

DIAMEDICA THERAPEUTICS INC.

Confidential Treatment Order (Form CT ORDER)

The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer diamedica therapeuti ...

22.12.2021
DiaMedica Therapeutics Inc.

DIAMEDICA THERAPEUTICS INC.

Quarterly Report (Form 10-Q)

Dmtp20210930_10q.htm united states securities and exchange commission washington, d.c. 20549 ______________________________ form 10-q (mark one) ☒ quarterly report pursuant to se ...

10.11.2021
DiaMedica Therapeutics Inc.

DIAMEDICA THERAPEUTICS INC.

Notice of Effectiveness (Form EFFECT)

The text version of this document is not available. you can access the original document here. attachments original document permalink disclaimer diamedica therapeutics inc. publis ...

15.10.2021
DiaMedica Therapeutics Inc.

DIAMEDICA THERAPEUTICS INC.

Supplemental Prospectus (Form 424B3)

Dmtp20211014_424b3.htm filed pursuant to rule 424(b)(3) registration statement no.: 333-260066 final prospectus 7,653,060 common shares this prospectus relates to the resale, from ...

15.10.2021
DiaMedica Therapeutics Inc.

DIAMEDICA THERAPEUTICS INC.

Notice of Sales of Unregistered Securities (SEC Filing - D)

The text version of this document is not available. you can access the original document here. attachments original document permalink disclaimer diamedica therapeutics inc. publis ...

06.10.2021
Condividi